CrackitToday App

Lenacapavir Drug

Kumari Sonali

Lenacapavir Drug:

The United States Food and Drug Administration (FDA) approved Lenacapavir (LEN), the most promising HIV prevention medicine to be made so far.

  • Lenacapavir is an antiretroviral medicine that is used for HIV prevention as a pre-exposure prophylaxis or PrEP.
  • PrEP is a medication that can reduce the risk of HIV infection for individuals who are HIV-negative but are at risk of contracting the virus.
  • The results of two key studies have shown that it helps prevent 99.9 percent of all HIV transmission.
  • LEN is an injectable PrEP that is to be taken twice yearly.
  • It is developed by Gilead Sciences and marketed under the brand name Yeztugo.
  • Lenacapavir is a capsid inhibitor, a class of drugs that blocks the protein shell (capsid) the HIV virus needs to replicate.
  • Unlike oral PrEP pills that must be taken daily, lenacapavir is administered as an injection once every six months, providing a discreet and highly effective method of prevention.

...Read more on our test console

...Read these too

  • Drug Repurposing

    Drug Repurposing: Researchers who have been working in the field of drug repurposing have found the repurpose potential of an antidepressant drug for cancer management. Drug Repurposing is the technique…

  • Donanemab : New Alzheimer’s Drug

    Donanemab : New Alzheimer’s Drug A new Alzheimer’s drug, donanemab, has received support from an FDA advisory committee, moving closer to approval. Intended for early-stage Alzheimer’s, it shows significant slowing…

  • Alzheimer’s : New Drug Found

    Alzheimer’s : New Drug Found A new drug, Gantenerumab, shows promise in slowing early-onset Alzheimer’s while significantly reducing amyloid plaque buildup, a key marker of the disease. Alzheimer’s disease is…